NEUROFIBROMA
Clinical trials for NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMA trials appear
Sign up with your email to follow new studies for NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug shrink painful NF1 skin tumors? early trial launches
Disease control Recruiting nowThis early study tests if a drug called IMLYGIC, already used for some skin cancers, can safely treat bothersome skin tumors in adults with NF1. Ten participants will receive injections directly into their tumors over four cycles. The goal is to see if the treatment is feasible a…
Matched conditions: NEUROFIBROMA
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New questionnaires aim to measure the emotional toll of visible tumors in NF1
Knowledge-focused Recruiting nowThis study is testing two questionnaires to see if they can capture how people with neurofibromatosis type 1 (NF1) feel about the appearance of their tumors. About 110 participants — including children, adults, and caregivers — will join focus groups or interviews to share their …
Matched conditions: NEUROFIBROMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 05:29 UTC